Eberechi Ekechukwu, MD
Emergency Medicine · Sibley, IANPI 1710418074
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $816 of the $916 with a category attached, or 89.1%. It is spread thinly across 12 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $438 and has fallen 87.0% since, to $57 in 2023. Among emergency medicine clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 48 payments — averaging $19.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$219
- Amgen$180
- AstraZeneca$164
- Johnson & Johnson$94
- AbbVie$84
- Novartis$45
- plus $131 from 6 others
What the payments were for
- Food & beverage$81689%
- Education$10011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 8 | $219 |
| Amgen | 12 | $180 |
| AstraZeneca | 3 | $164 |
| Johnson & Johnson | 7 | $94 |
| AbbVie | 5 | $84 |
| Novartis | 3 | $45 |
| Merck | 3 | $36 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $30 |
| Novo Nordisk | 2 | $26 |
| Amarin Pharma, Inc. | 1 | $14 |
| Bayer | 1 | $13 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYNPARZA$123
How this compares
$916 in reported general payments places this provider in the 95th percentile of 360 emergency medicine providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enalapril Maleate | 13 | $565 |
| Levothyroxine Sodium | 22 | $172 |
| Baclofen | 19 | $44 |
| Azithromycin | 19 | $39 |
| Prednisone | 16 | $33 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Sibley
- Anthony CarterCedar Rapids$408K
- Thomas WernimontAmes$134K
- David TalanIowa City$48K
- Hijinio CarreonDes Moines$25K
- Todd SextonDes Moines$5K
- Philip SpanheimerIowa City$5K
- Scott MurraySioux City$5K
- Mohammad KotobIowa City$3K
- Ryan BakkeNewton$3K
- Daniel RundeIowa City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.